iKinnect2.0 App for Suicide Risk in Youth
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests an app called iKinnect2.0 to help reduce suicide risk in young people involved with the juvenile justice system. The study compares iKinnect2.0 with a control app, Life360, to determine which provides more effective support to youth and their caregivers. The trial targets youth aged 15-21 who have been arrested and are at significant risk for suicide, along with their primary caregivers. The goal is to assess whether the app can improve coping strategies and parent-youth relationships, ultimately reducing the risk of suicide. Participants will use the app regularly over a 16-week period. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could significantly impact the well-being of at-risk youth.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that the iKinnect2.0 app is safe for youth?
Research shows that iKinnect2.0 aims to reduce risky behaviors in young people, including those related to suicide and self-harm. Although specific safety data on the iKinnect2.0 app is not available, the app serves as a tool to prevent harmful actions by providing support and resources to improve mental health.
The study is labeled as "Not Applicable" in terms of phase, indicating it is not a traditional drug or medical device trial. Instead, it examines the app's usage and its impact on behavior. Generally, mental health support apps are considered safe, as they do not involve invasive procedures or medications.
In summary, while specific safety data for iKinnect2.0 is lacking, the app aims to create a safe and supportive environment to help young people manage suicidal thoughts and behaviors. Prospective participants should know that the app's primary purpose is to offer mental health resources and support, which are generally safe.12345Why are researchers excited about this trial?
Researchers are excited about the iKinnect2.0 app because it offers a novel approach to managing suicide risk in youth through digital intervention. Unlike traditional therapies that often require in-person sessions with mental health professionals, iKinnect2.0 provides a convenient, accessible option that can be used anytime via a mobile app. This app is designed to engage users multiple times a day, potentially increasing its effectiveness by integrating support into daily life. By leveraging technology, iKinnect2.0 aims to provide timely resources and support, which could significantly enhance existing treatment methods for young people at risk.
What evidence suggests that the iKinnect2.0 app is effective for reducing suicide risk in youth?
Research has shown that iKinnect2.0, an app tested in this trial, might help reduce suicidal thoughts and behaviors in young people within the juvenile justice system. Studies have found that users of iKinnect2.0 report fewer issues with self-harm and behavior. Additionally, parents of these young people often feel more confident in preventing suicide and managing parenting challenges. The app includes tools to help young people manage stress and improve mental health. These early results suggest it could effectively prevent suicide.12356
Who Is on the Research Team?
Cindy Schaeffer, PhD
Principal Investigator
University of Maryland
Linda A. Dimeff, PhD
Principal Investigator
Evidence-Based Practice Institute
Are You a Good Fit for This Trial?
This trial is for English-speaking youth aged 15-21 at high risk of suicide, with a history of self-harm or attempts, who use a smartphone with data and live with their primary caregiver. Caregivers must also participate, be fluent in English, and have a smartphone. Youth should be involved in juvenile justice services.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pilot Testing
Usability and acceptability testing of iKinnect2.0 features with target end-users and stakeholders
Randomized Controlled Trial
Participants are randomly assigned to iKinnect2.0 or Life360 control app for a 16-week trial to test the efficacy of iKinnect2.0 in reducing suicidal behaviors and improving coping strategies
Follow-up
Participants are monitored for safety and effectiveness after the trial
What Are the Treatments Tested in This Trial?
Interventions
- Active Control App
- iKinnect2.0
Trial Overview
The study compares iKinnect2.0, an app designed to help prevent suicide among young people involved in the juvenile justice system, against Life360 (a control app) plus electronic resources on suicide prevention over a period of 16 weeks.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Parent-Youth dyads assigned to the iKinnect2.0 condition will be given access to the iKinnect2.0 app that has been developed for this study. Parent and youth will be asked to download the app to their phone during the baseline assessment process and asked to use it as often as they would like throughout the duration of the 16 week trial. The app is designed to be used several times throughout each day.
Parent-Youth dyads assigned to the control condition will be asked to download the free Life360 app to their phone during the baseline assessment process and will also be given access to an online suicide resources brochure. Participants will be asked to use the control-condition app and associated materials as often as they would like throughout the duration of the 16 week trial.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Evidence-Based Practice Institute, Seattle, WA
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator
University of Maryland
Collaborator
Published Research Related to This Trial
Citations
1.
clinicaltrials.gov
clinicaltrials.gov/study/NCT04909203?spons=COVERAGE%5BFullMatch%5DEXPANSION%5BNone%5D(%22Evidence-Based%20Practice%20Institute,%20Seattle,%20WA%22)&viewType=Table&rank=2iKinnect2.0 for Juvenile Justice Involved Youth at Risk ...
0 participants will report a significantly greater decrease in youths' suicidal, NSSI, and conduct-problem behaviors, and less recidivism. Furthermore, ...
iKinnect2.0 for Juvenile Justice Involved Youth at Risk f...
iKinnect parents will report greater increases in parenting and suicide prevention efficacy. iKinnect youth will report greater decreases in ...
iKinnect2.0 App for Suicide Risk in Youth
Trial Overview The study compares iKinnect2.0, an app designed to help prevent suicide among young people involved in the juvenile justice system, against ...
4.
aging.networkofcare.org
aging.networkofcare.org/sanmateo/CommunityResources/ClinicalTrials/Detail/NCT04909203?keyword=%22Self-Harm%22iKinnect2.0 for Juvenile Justice Involved Youth at Risk ...
iKinnect parents will report greater increases in parenting and suicide prevention efficacy.~2. iKinnect youth will report greater decreases in suicidal, NSSI, ...
About
iKinnect2.0 extends the original technology by building in powerful suicide prevention tools to reduce teen suicide. In addition to its original features ...
6.
aging.networkofcare.org
aging.networkofcare.org/sanmateo/CommunityResources/ClinicalTrials/Detail/NCT04909203?keyword=%22Suicidality%22iKinnect2.0 for Juvenile Justice Involved Youth at Risk ...
This project seeks to significantly expand iKinnect to prevent NSSI, suicidal behaviors (ideation, planning, attempts), and death by suicide in JJ-involved ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.